APA (7th ed.) Citation

P, R., SI, S., EJ, G., RH, H., J, S., H, D., . . . S, S. (2019). Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment study. Journal of viral hepatitis, 26(6), 770. https://doi.org/10.1111/jvh.13067

Chicago Style (17th ed.) Citation

P, Ruane, et al. "Sofosbuvir/Velpatasvir/Voxilaprevir for Patients with HCV Who Previously Received a Sofosbuvir/Velpatasvir-containing Regimen: Results from a Retreatment Study." Journal of Viral Hepatitis 26, no. 6 (2019): 770. https://doi.org/10.1111/jvh.13067.

MLA (9th ed.) Citation

P, Ruane, et al. "Sofosbuvir/Velpatasvir/Voxilaprevir for Patients with HCV Who Previously Received a Sofosbuvir/Velpatasvir-containing Regimen: Results from a Retreatment Study." Journal of Viral Hepatitis, vol. 26, no. 6, 2019, p. 770, https://doi.org/10.1111/jvh.13067.